Department of Cardiovascular Medicine, Northern Jiangsu People's Hospital, Yangzhou, Jiangsu Province, China.
Acta Cardiol. 2024 Sep;79(7):751-760. doi: 10.1080/00015385.2024.2391132. Epub 2024 Aug 15.
Rs1333040 is the single-nucleotide polymorphisms (SNP) related with coronary heart disease (CHD). The aim of the present study is to examine the association between rs1333040 polymorphism genotypes and CHD and to further explore the molecular mechanism in Chinese population.
A case-control study was used in this study, including 500 CHD patients and 500 control subjects. CHD patients and controls were distinguished by coronary angiography. Genotypes of rs1333040 were determined on the Agena MassARRAY system. Statistical analysis was conducted by SPSS (Ver 16.0) and plink (Ver. 1.07, Shaun Purcell).
Fisher's exact test by plink indicated a significant difference in the allele distribution between cases and controls, the allele T may be associated with a higher risk of CHD ( = 0.012, odds ratio (OR) = 1.258). The serum levels of low-density lipoprotein cholesterol (LDL-C) ( = 0.029) and Gensini score ( = 0.008) distributed differently in patients with various alleles. In the recessive model, the levels of high-density lipoprotein (HDL) and apolipoprotein A (ApoA) were higher in the TC + CC genotype than in the TT genotype. The TC + TT genotype was found to be risk factors against CHD in a dominant model (OR = 1.278, = 0.014). The TC + TT genotype along with multiple risk factors significantly positively correlated with the risk of CHD.
The present study investigates the association between the rs1333040 polymorphism genotypes and CHD. The T allele of rs1333040 is the susceptibility site of CHD. The interaction between SNP and various risk factors plays an important role in the development of CHD.
Rs1333040 是与冠心病 (CHD) 相关的单核苷酸多态性 (SNP)。本研究旨在探讨 rs1333040 多态性基因型与 CHD 的相关性,并进一步探讨中国人群中的分子机制。
本研究采用病例对照研究,包括 500 例 CHD 患者和 500 例对照。通过冠状动脉造影区分 CHD 患者和对照组。采用 Agena MassARRAY 系统检测 rs1333040 的基因型。采用 SPSS(Ver 16.0)和 plink(Ver. 1.07,Shaun Purcell)进行统计分析。
plink 中的 Fisher 确切检验表明,病例组和对照组之间的等位基因分布存在显著差异,等位基因 T 可能与 CHD 的较高风险相关(=0.012,优势比(OR)=1.258)。不同等位基因患者的血清低密度脂蛋白胆固醇(LDL-C)(=0.029)和 Gensini 评分(=0.008)分布不同。在隐性模型中,TC+CC 基因型的高密度脂蛋白(HDL)和载脂蛋白 A(ApoA)水平高于 TT 基因型。在显性模型中,TC+TT 基因型被发现是 CHD 的危险因素(OR=1.278,=0.014)。TC+TT 基因型与多种危险因素共同显著正相关,与 CHD 风险相关。
本研究探讨了 rs1333040 多态性基因型与 CHD 的相关性。rs1333040 的 T 等位基因是 CHD 的易感位点。SNP 与各种危险因素的相互作用在 CHD 的发生发展中起着重要作用。